Gene therapy for children with sickle cell disease approved by FDA

Дата публикации: 08-07-2026 14:31:09

A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia	0	10.55	19-08-2026
2	FDA Approves New ADHD Medication	0	9.53	14-08-2026
3	Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease	0	16.67	28-05-2026
4	Skyrizi (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease	0	13.95	26-06-2026
5	Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes	0	22.68	12-06-2026
6	New drug cuts seizures by up to 91% in children with rare epilepsy	0	8.26	05-03-2026
7	Разработана генная терапия от детской кардиомиопатии	0	13.31	19-08-2026
8	GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome	0	15.62	12-06-2026
9	FDA Approves First Freeze-Dried Plasma Product in the U.S.	0	8.05	17-08-2026
10	Liquid cavity treatment, used in other countries, could benefit U.S. kids, researchers say	0	6.33	30-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: thehill.com.